Past performance
About Caplin Point Laboratories Ltd Caplin Point Laboratories Limited, founded by Mr. C. C. Paarthipan in 1990, is a fully integrated pharmaceutical company involved in the production, development, and marketing of generic formulations and branded products globally. With over 4000 product registrations and 650 pharmaceutical formulations, Caplin serves 23 countries, including regulated markets such as the US and EU. The company's facilities include a manufacturing plant in Puducherry and R&D in Tamil Nadu, India, with approvals from global regulatory bodies like the US FDA and EU-GMP.
Caplin has expanded its market presence through strategic partnerships, such as the joint venture in China, and investments, forming Caplin Steriles Limited to enhance its injectable product line. The firm actively enhances its infrastructure, recently doubling its Softgel production capacity and acquiring an API plant in Andhra Pradesh. It also utilizes advanced technology like SAP's S4 HANA system for improved operations. Caplin's robust product pipeline and strategic expansions position it strongly in the global pharmaceutical landscape.
Performance overview